In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

More than 700,000 Medicare beneficiaries currently face permanent increases in their Part B premiums because of late enrollment, with average penalties reaching 30 percent.

Medicare Part B drug negotiations in 2028 pose challenges for providers, requiring new payment systems and strategies to ...

Medicare Advantage may lure seniors with slick perks and shiny star ratings, but many soon find themselves tangled in red ...

While many MA beneficiaries appreciate the flexibility of choosing their own support, others face barriers like limited card ...

There is a nearly five-year gap between when a new medical device receives FDA approval and is subsequently covered by ...

It is not income-based. Anyone who receives Medicare Part A and/or Part B is also eligible for Part D. The decision to enroll and which plan to choose should be made in consideration with one’s ...

For retirees living on fixed Social Security benefits, every dollar counts, especially when it comes to healthcare. Medicare ...

Harrow has successfully leveraged its compounding pharmacy to drive rapid branded drug growth. My valuation suggests ...

Medicare enrollees will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that could lead to huge ...

GoodRx notes it’s a good idea to explore your health insurance options before you quit your job and employment-based coverage expires.

Beneficiaries’ initial enrollment choices, whether active or passive, tend to have long-lasting implications because ...